Invesco Health Care Fund is a registered fund series of AIM Investment Funds (Invesco Investment Funds) (series S000000235). Net assets $1.1B as of 2026-04-30.
Showing 15 of 81 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly and Co. | — | $109.2M | 965.19% |
| Johnson & Johnson | — | $66.1M | 584.55% |
| AstraZeneca PLC | — | $47.3M | 418.01% |
| Gilead Sciences, Inc. | — | $44.1M | 389.78% |
| UnitedHealth Group Inc. | — | $42.9M | 378.85% |
| argenx SE | — | $41.4M | 366.08% |
| AbbVie Inc. | — | $40.9M | 361.81% |
| McKesson Corp. | — | $38.8M | 342.68% |
| Cencora, Inc. | — | $35.2M | 311.57% |
| Invesco Private Prime Fund | — | $34.1M | 301.11% |
| Welltower Inc. | — | $26.2M | 231.40% |
| Merck & Co., Inc. | — | $25.6M | 226.69% |
| BrightSpring Health Services, Inc. | — | $23.1M | 204.46% |
| Regeneron Pharmaceuticals, Inc. | — | $22.9M | 202.11% |
| Royalty Pharma PLC | — | $22.1M | 195.27% |
| Report date | Net assets |
|---|---|
| 2026-04-30 | $1.1B |
| 2026-01-31 | $1.2B |
| 2025-10-31 | $1.3B |
| 2025-07-31 | $1.1B |
| 2025-04-30 | $1.2B |
| 2025-01-31 | $1.3B |
| 2024-10-31 | $1.3B |
| 2024-07-31 | $1.4B |